Protocol to study molecule exchange between venous blood and CSF in live mice using transcranial bioluminescence imaging.

Autor: Esmail T; Division of Glial Disease and Therapeutics, Center for Translational Neuromedicine, University of Copenhagen, 2200 Copenhagen, Denmark. Electronic address: tina.esmail@sund.ku.dk., Nedergaard M; Division of Glial Disease and Therapeutics, Center for Translational Neuromedicine, University of Copenhagen, 2200 Copenhagen, Denmark; Division of Glial Disease and Therapeutics, Center for Translational Neuromedicine, Department of Neurosurgery, University of Rochester Medical Center, Rochester, NY 14642, USA., Beinlich FRM; Division of Glial Disease and Therapeutics, Center for Translational Neuromedicine, University of Copenhagen, 2200 Copenhagen, Denmark. Electronic address: felix.beinlich@sund.ku.dk.
Jazyk: angličtina
Zdroj: STAR protocols [STAR Protoc] 2023 Dec 15; Vol. 4 (4), pp. 102652. Date of Electronic Publication: 2023 Oct 25.
DOI: 10.1016/j.xpro.2023.102652
Abstrakt: In bioluminescence imaging (BLI), the biochemical reaction between a substrate and enzyme triggers light emission upon convergence. Unlike fluorescence imaging, BLI does not require excitation. In this protocol, we utilize the high signal-to-background ratio of the reaction between luciferase and its substrate to study the exchange of molecules between blood and cerebrospinal fluid. We outline steps for skull window thinning, cisterna magna infusion, intravascular retro-orbital injection, and imaging. For complete details on the use and execution of this protocol, please refer to Møllgård et al. (2023). 1 .
Competing Interests: Declaration of interests The authors declare no competing interests.
(Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.)
Databáze: MEDLINE